-
"Every encounter an ED nurse has with a trauma patient and family makes a definite impression on their lives," says Carrie L. Baumann, RN, BSN, patient care supervisor in the Emergency Department Trauma Center at Children's Hospital of Wisconsin in Milwaukee.
-
You might see only a handful of pediatric trauma cases every year, but chances are you will see at least one. This is a dangerous "low-volume, but high-risk" patient for most emergency nurses. Here are some common misconceptions about these patients:
-
At Emory Johns Creek (GA) Hospital, ED nurses have noticed that many patients with psychiatric complaints actually are looking for help with drug and alcohol addictions, reports Mickey White, RN, BSN, MBA, director of the ED.
-
(Editor's note: This story is part one of a two-part series on care of psychiatric patients in the ED. This month, we give tips for identifying underlying medical conditions. Next month, we'll share the best ED nursing practices for reassessment during long waits.)
-
Accreditation for an academic research institution is a time-consuming and difficult process for the research office and the institution's IRB office. But for a small, private research organization, the task is Herculean.
-
IRB Advisor: Dr. Marjorie Speers, would you please explain how AAHRPP accreditation requirements work with regard to institutions that are seeking accreditation and have plans to use foreign IRBs for a multi-site study that includes clinical trials located in other countries? Foreign countries hosting clinical trials often require a local board to review the study.
-
Barbara Bierer, MD, professor of medicine at Harvard Medical School, and the senior vice president for research and the director of faculty development and diversity at Brigham and Women's Hospital in Boston, MA, is the new chair of the U.S. Health and Human Services (HHS) Secretary's Advisory Committee on Human Research Protections (SACHRP).
-
People participating in pain research report having complex combinations of reasons for enrolling part altruism, part seeking new treatments, part simply having their pain understood and taken seriously.
-
IRBs striving to ensure they're not inadvertently approving a seeding trial have a tough job ahead of them.
-
Many in IRB circles have worried about the potential existence of "seeding" trials, which are defined as clinical trials that seek to market a product rather than answer a legitimate scientific question.
